Patented Technology, Bioteke Monkeypox Detection Solutions - Helping Public Health

In August 2024, the World Health Organization (WHO) declared mpox (formerly known as monkeypox) a "public health emergency of international concern" (PHEIC), its highest level of alert under international health law (UN News). This decision followed a significant surge in mpox cases, particularly in Africa, with over 14,000 reported cases and more than 500 deaths. The outbreak is driven by more virulent clades of the virus, including a particularly deadly strain found in the Democratic Republic of Congo (UN News).

The declaration calls for a coordinated global response, focusing on equitable access to vaccines, diagnostics, and treatment, particularly in low-income countries. WHO has been working with governments and organizations like the Africa CDC to support case investigations, contact tracing, and laboratory efforts. (Kansas Public Radio).

The emergence and rapid spread of a new strain of the virus (clade 1b) in the Democratic Republic of the Congo last year, which appears to be spread mainly through sexual networks, and has also been found in neighboring countries of the Democratic Republic of the Congo, is particularly worrying and is one of the main reasons for declaring a Public Health Emergency of International Concern.

In the past month, four neighboring countries of the Democratic Republic of the Congo, Burundi, Kenya, Rwanda and Uganda, have reported more than 100 laboratory-confirmed cases of clade 1b, which had never previously reported cases of monkeypox. Experts believe that the true number of cases may be higher because most clinically compatible cases are not tested.

WHO is working with countries and vaccine manufacturers and coordinating with partners through the Temporary Medical Countermeasures Network to promote access to vaccines, treatments, diagnostics and other tools.

In this context, Bioteke responded quickly to global public health needs and launched its own patented product: Monkeypox Virus Nucleic Acid Detection Kit(Fluorescence PCR). This solution is based on advanced nucleic acid detection technology, which can quickly and accurately detect the presence of monkeypox virus, effectively helping medical institutions, CDCs and other units to quickly identify infected people and take isolation and treatment measures. Bioteke's monkeypox virus nucleic acid detection diagnostic solution can detect multiple virus strains, including the more deadly type 1b virus strain reported by WHO, and is particularly suitable for high-risk areas and outbreak points.

At the same time, Bioteke's new product, Monkeypox Virus Rapid Antigen Test Kit, is about to go into mass production and enter the market, contributing to the development of global public health.

Why choose Bioteke's monkeypox virus Diagnostic Solutions?

a. Efficient and accurate: Bioteke's nucleic acid detection solution uses fluorescent PCR technology, which can quickly and accurately detect monkeypox virus genes, with high diagnostic sensitivity, and is suitable for all types of medical laboratories.

b. Rapid response: Bioteke's detection solution is designed as a flexible detection system that can respond to sudden infections and provide results in a short time to help control the spread of the epidemic.

c. Global certification: The detection solution complies with international standards such as ISO13485 and CE, and has obtained registration certification in many countries and regions to ensure product quality and reliability.

d. Supporting public health efforts: Bioteke not only provides testing solutions, but is also willing to work with health agencies in various countries to provide equipment, test kits, technical support, etc. to assist global public health agencies in responding to the challenges of monkeypox virus.

Website: www.bioteke.cn

Whatsapp: +86 181 1536 3743

Youtube: https://www.youtube.com/@BiotekeZhou

Linkedin: https://www.linkedin.com/in/bioteke-hu-502b43283/

Contact us now to get more IVD product information and the opportunity to try the latest R&D products.